Trials / Completed
CompletedNCT02792595
In Vivo Sun Protection Factor Determination
Sun Protection Factor Determination (In Vivo Determination of the Sun Protection Factor ISO 24444) (61-SPF-iM)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The study aims to determine the Sun Protection Factor (SPF) of 8 cosmetic products in vivo on the back of human participants, according to the International Standard Sun Protection Test method by using a sun simulator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Negative Control | Untreated area |
| OTHER | Positive Control | High SPF Standard P3/SPF 15 |
| OTHER | Test Product A | Yosemite Falls (Forte Day SPF upgrade) Variant A |
| OTHER | Test Product B | Yosemite Falls (Forte Day SPF upgrade) Variant B |
| OTHER | Test Product C | Yosemite Falls (Forte Day SPF upgrade) Variant C |
| OTHER | Test Product D | Yosemite Falls (Forte Day SPF upgrade) Variant D |
| OTHER | Test Product E | Yosemite Falls (Forte Day SPF upgrade) Variant E |
| OTHER | Test Product F | Yosemite Falls (Forte Day SPF upgrade) Variant F |
| OTHER | Test Product G | Yosemite Falls (Forte Day SPF upgrade) Variant G |
| OTHER | Test Product H | Yosemite Falls (Forte Day SPF upgrade) Variant H |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2016-06-07
- Last updated
- 2016-06-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02792595. Inclusion in this directory is not an endorsement.